Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 7, 1996, Pages 555-560

  Leto, Gaetano ^a   Tumminello, Francesca Maria ^a   Pizzolanli, Giuseppe ^a   Gebbia, Nicola ^a   Montalto, Giuseppe ^b   Soresi, Maurizio ^b   Ruggeri, Irene ^b  

^a Servizio di Chemioterapia   (Japan)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CATHEPSIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FATTY LIVER; FEMALE; HUMAN; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CATHEPSIN D; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0029766543     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.7.555     Document Type: Article

References (34)

1. Barrett A. J., Cathepsin D and other carboxyl proteinases. In: Barrett A. J., editor. Proteinases in mammalian cells and tissues. Amsterdam: Elsevier/North Holland Biomed Press, 1977:209-229.
2. Rochefort H. Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol 1992; 31:125-130.
3. Leto G., Gebbia N., Rausa L., Tumminello F. M., Cathepsin D in the malignant progression of neoplastic disease [review]. Anticancer Res 1992; 12:235-240.
4. Solovyeva N. I., Balayevskaya T. O., Dilakyan E. A., Zakaldamazina-Zama T. A., Podznev V. F., Topol L. Z., et al, Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases. Int J Cancer 1995; 60:495-500.
5. Fusek M., Větvička V. Mitogenic function of procathepsin D: the role of propeptide. Biochem J 1994; 303:775-780.
6. Větvička V., Větvičková J, Fusek M. Effects of human procathepsin D on proliferation of human cell lines. Cancer Lett 1994; 79 (2): 131-5.
7. Fontanini G., Bigini D., Vignati S., Ribechini A., Angeletti C. A., Pingitore R. Immunostaining of cathepsin D in non-small cell lung cancer: correlation with morphological and biological parameters. Int J Oncol 1994; 4:169-173.
8. Leto G., Tumminello F. M., Russo A., Pizzolanti G., Bazan V., Gebbia N. Cathepsin D activity levels in colorectal cancer: correlation with cathepsin B and L and other biological and clinical parameters. Int J Oncol 1994; 5:509-515.
9. Marsigliante S., Biscozzo L., Resta L., Leo G., Mottaghi A., Maiorano E., et al, Immunohistochemical and immunoradiome-tric evaluations of total cathepsin D in human larynx. Eur J Cancer 1994; 30B:51-55.
10. Nazeer T., Malfetano J. H., Rosano G. T., Ross J. S., Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Am J Clin Pathol 1992; 97:764-769.
11. Podhajcer O. L., Bover L., Bravo A. l., Ledda F., Kariyama C., Calb I., et al, Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi. J Invest Dermatol 1995; 104:340-344.
12. Scambia G., Panici B. P., Ferrandina G., Salerno G., D'Agostino G., Distefano M., et al, Clinical significance of cathepsin D in primary ovarian cancer. Eur J Cancer 1994; 30A:935-940.
13. Zeillinger R., Swoboda H., Machacek D., Nekham D., Sliutz G., Knogler W., et al, Expression of cathepsin D in head and neck cancer. Eur J Cancer 1992; 28A (8-9):1413-1415.
14. Maguchi S., Taniguchi N., Makita A. Elevated activity and increased mannose-6-phosphate in the carbohydrate moiety of cathepsin D ffom human hepatoma. Cancer Res 1988; 48:362-367.
15. Brouillet J. P., Hanslick B., Maudelonde T., Pivat M. P., Grenier J., Blanc F., et al, Increased plasma cathepsin D concentrations in hepatic carcinoma and cirrhosis but not in breast cancer. Clin Biochem 1991; 24:491-496.
16. Isidoro C., Demoz M., De Stefanis D., Mainferme F., Wattiaux R., Baccino F. M., Altered intracellular processing and enhanced secretion of procathepsin D in a highly deviated rat hepatoma. Int J Cancer 1995; 60:61-64.
17. Isidoro C., Demoz M., Baccino F. M., Bonelli G. High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma. Invasion Metastasis 1995; 15:116-124.
18. Ryvnyak V. V., Gudumak V. S., Onya E. S., Intracellular and extracellular cathepsin D activity in the liver during cirrhosis and involution. Bull Exp Biol Med Engl Trans 1990; 109 (2):250-253.
19. Johnson P. J., Williams K. Cirrhosis and aetiology of hepatocellular carcinoma. J Hepatol 1987; 4:140-147.
20. Colombo M., De Franchis D., Del Ninno E., Sangiovanni A., De Fazio C., Tommasini M., et al, Hepatocellular carcinoma in Italian patients with cirrhosis. New Engl J Med 1991; 325 (10):675-680.
21. Theisen N. D., Fiel I. M., Hytiroglou P., Schwarz M., Miller C., Thung S. N., Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alpha-fetopro-tein. Liver 1995; 15:30-34.
22. Pugh RNH, Murray Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
23. Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990; 12:1420-1432.
24. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6:729-738.
25. Zühldorf M., Imort M., Hasiiik A., von Figura K. Molecular forms of beta-hexosaminidase and cathepsin D in serum and urine of healthy subjects and patients with elevated activity of lysosomal enzymes. Biochem J 1983; 213:733-740.
26. Reid W., Valler M. J., Kay J. Immunolocalisation of cathepsin D in normal and neoplastic human tissues. J Clin Pathol 1986; 39:1323-1330.
27. Huet G., Zerimech F., Dieu M. C., Hemon B., Grard G., Balduyck M., et al, The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator. Int J Cancer 1994; 57:875-882.
28. Morioka M., Terayama H. Cathepsin D stimulates DNA-syn-thesis and mitosis in mouse liver in vivo. Exp Cell Res 1982; 151:273-276.
29. Terayama H., Morioka M., Koij T. Mitogenic effects of certain cathepsins and calciferin on intact liver in vivo. Int J Biochem 1985; 17:945-955.
30. Terayama H., Shimuzu N., Fukuzumi R. Calciferin and cathepsin D-like acid protease in serum in acute and chronic liver injuries in rats and humans. Clin Chem 1989; 35-11:2202-2206.
31. Murawaki Y., Yamada S., Koda M., Hirayama C. Collagenase and collagenolytic cathepsin in normal and fibrotic rat liver. J Biochem 1990; 108:241-244.
32. Dufiy M. J., The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Met 1992; 10:145-155.
33. Hann H-WL, Kim C. J., London W. T., Blumberg B. S., Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer 1989; 43:376-379.
34. Tsai J. F., Jeng J. E., Ho M. S., Chang W. Y., Lin Z. Y., Tsai J. H., Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Br J Cancer 1995; 72 (2):442-446.